Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v1-EN
Language French English
Date Updated 2023-05-01 2022-12-20
Drug Identification Number 02287145 02287145
Brand name FOSRENOL FOSRENOL
Common or Proper name Lanthanum carbonate hydrate chewable tablets Lanthanum carbonate hydrate chewable tablets
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients LANTHANUM LANTHANUM
Strength(s) 250MG 250MG
Dosage form(s) TABLET (CHEWABLE) TABLET (CHEWABLE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size Bottles of 90 tablets Bottles of 90 tablets
ATC code V03AE V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2023-04-30 2023-03-31
Actual discontinuation date 2023-04-30
Remaining supply date 2023-04-30 2023-03-31
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments